##plugins.themes.bootstrap3.article.main##

##plugins.themes.bootstrap3.article.sidebar##

Published Sep 29, 2024

Madison Yan

Sonja Schmidt  

Abstract

COVID-19 vaccination has been a critical tool in the global fight against the pandemic, offering hope for a return to normalcy. While the immediate side effects of vaccination are well-documented and generally mild, concerns around potential long-term complications have emerged. This article explores the reported long-term complications following COVID vaccination, factors influencing these outcomes, and strategies for managing and addressing them. By delving into research findings and offering recommendations, we aim to provide valuable insights for individuals navigating the complexities of post-vaccination health concerns.

##plugins.themes.bootstrap3.article.details##

Keywords

COVID-19, Vaccination, Complications, Interventions, Post-vaccination Health

Supporting Agencies

No funding source declared.

References
Acevedo-Whitehouse, K., & Bruno, R. (2023). Potential health risks of mRNA-based vaccine therapy: A hypothesis. Medical Hypotheses, 171, 111015. DOI: https://doi.org/10.1016/j.mehy.2023.111015

Afrashtehfar, K. I., Jurado, C. A., Abu-Fanas, S. H., & Jaber, M. A. (2023). Health and well-being through COVID-19 vaccination: Physical, oral, and psychological effects. International Journal of Environmental Research and Public Health, 20(4), 3117. DOI: https://doi.org/10.3390/ijerph20043117

Almalki, M. E., Alshumrani, F. A., Almalki, H. A., Saati, A. A., Alzahrani, S. E., & Khouj, S. M. (2023). Regional myopericarditis mimicking inferior myocardial infarction following COVID-19 vaccination: A rare adverse event. Cureus 15(6), e41168. DOI: https://doi.org/10.7759/cureus.41168

Al-Rousan, N., & Al-Najjar, H. (2024). Evaluation of the effects of MERCK, MODERNA, PFIZER/BioNTech, and JANSSEN COVID-19 vaccines on vaccinated people: A metadata analysis. Informatics in Medicine Unlocked, 49, 101564. DOI: https://doi.org/10.1016/j.imu.2024.101564

Banerji, A., Wickner, P. G., Saff, R., Stone, C. A., Robinson, L. B., Long, A. A., Wolfson, A. R., Williams, P., Khan, D. A., Phillips, E., & Blumenthal, K. G. (2020). mRNA vaccines to prevent COVID-19 disease and reported allergic reactions: Current evidence and suggested approach. The Journal of Allergy and Clinical Immunology in Practice, 9(4), 1423-1437. DOI: https://doi.org/10.1016/j.jaip.2020.12.047

Bhandari, B., Rayamajhi, G., Lamichhane, P., & Shenoy, A. K. (2022). Adverse events following immunization with COVID-19 vaccines: A narrative review. BioMed Research International, 2022, 1-11. DOI: https://doi.org/10.1155/2022/2911333

Bolze, A., Mogensen, T. H., Zhang, S., Abel, L., Andreakos, E., Arkin, L. M., Borghesi, A., Brodin, P., Hagin, D., Novelli, G., Okada, S., Peter, J., Renia, L., Severe, K., Tiberghien, P., Vinh, D. C., Aiuti, A., Al-Muhsen, S., Al-Mulla, F., . . . Hsieh, E. W. Y. (2022). Decoding the human genetic and immunological basis of COVID-19 mRNA vaccine-induced myocarditis. Journal of Clinical Immunology, 42(7), 1354-1359. DOI: https://doi.org/10.1007/s10875-022-01372-9

Bozkurt, B., Kamat, I., & Hotez, P. J. (2021). Myocarditis with COVID-19 mRNA vaccines. Circulation, 144(6), 471-484. DOI: https://doi.org/10.1161/circulationaha.121.056135

Cankat, S., Demael, M. U., & Swadling, L. (2023). In search of a pan-coronavirus vaccine: Next-generation vaccine design and immune mechanisms. Cellular and Molecular Immunology, 21(2), 103-118. DOI: https://doi.org/10.1038/s41423-023-01116-8

De Sousa, P. M. B., Silva, E. A., Campos, M. a. G., Lages, J. S., Da Graça Carvalhal Frazão Corrêa, R., & Silva, G. E. B. (2024). Fatal myocarditis following COVID-19 mRNA immunization: A case report and differential diagnosis review. Vaccines, 12(2), 194. DOI: https://doi.org/10.3390/vaccines12020194

Dighriri, I. M., Alhusayni, K. M., Mobarki, A. Y., Aljerary, I. S., Alqurashi, K. A., Aljuaid, F. A., Alamri, K. A., Mutwalli, A. A., Maashi, N. A., Aljohani, A. M., Alqarni, A. M., Alfaqih, A. E., Moazam, S. M., Almutairi, M. N., & Almutairi, A. N. (2022). Pfizer-BioNTech COVID-19 Vaccine (BNT162b2) side effects: A systematic review. Cureus, 14(3), e23526. DOI: https://doi.org/10.7759/cureus.23526

Dutta, A. K. (2020). Vaccine against Covid-19 disease - Present status of development. The Indian Journal of Pediatrics, 87(10), 810-816. DOI: https://doi.org/10.1007/s12098-020-03475-w

Edgerley, S., Jeimy, S., & Zhu, R. (2022). Adverse cutaneous reactions after mRNA SARS-CoV-2 vaccination in 3 patients: A spectrum of severity. Canadian Medical Association Journal, 194(23), E807-E811. DOI: https://doi.org/10.1503/cmaj.220435

Elhassan, M., Ahmad, H., Mohamed, M., Saidahmed, O., & Elhassan, A. E. (2021). From muscles to wires: Report of two cases and literature review on COVID-19 vaccination and cardiac conduction disturbance. Cureus, 13(10), e18805. DOI: https://doi.org/10.7759/cureus.18805

Escudero, C., Prieto-Montaño, P., & Audicana, M. T. (2022). Adverse reactions to anti-infective vaccines: An emerging problem in the COVID-19 era. Current Treatment Options in Allergy, 9(3), 250-272. DOI: https://doi.org/10.1007/s40521-022-00311-8

Fadah, K., Abolbashari, M., Ojha, C., & Alkhateeb, H. (2022). Acute myopericarditis after first dose of mRNA-1273 SARS-CoV-2 vaccine in a young adult. Cureus, 14(2), e22111. DOI: https://doi.org/10.7759/cureus.22111

Faghihi, H., Mottaghi-Dastjerdi, N., Sharifzadeh, M., & Kakavandi, N. R. (2023). ChAdOx1 nCoV-19 vaccine and thrombosis with thrombocytopenia syndrome among adults: A systematic review. Advanced Pharmaceutical Bulletin, 13(4), 723-735. DOI: https://doi.org/10.34172/apb.2023.081

Fazal, Z. Z., Sen, P., Joshi, M., Ravichandran, N., Lilleker, J. B., Agarwal, V., Kardes, S., Kim, M., Day, J., Makol, A., Milchert, M., Gheita, T., Salim, B., Velikova, T., Gracia-Ramos, A. E., Parodis, I., Nikiphorou, E., Tan, A. L., Chatterjee, T., . . . Arredondo, G. (2022). COVAD survey 2 long-term outcomes: Unmet need and protocol. Rheumatology International, 42(12), 2151-2158. DOI: https://doi.org/10.1007/s00296-022-05157-6

Fontanet, A., & Cauchemez, S. (2020). COVID-19 herd immunity: Where are we? Nature Reviews. Immunology, 20(10), 583-584. DOI: https://doi.org/10.1038/s41577-020-00451-5

Fragkou, P. C., & Dimopoulou, D. (2021). Serious complications of COVID-19 vaccines: A mini-review. Metabolism Open, 12, 100145. DOI: https://doi.org/10.1016/j.metop.2021.100145

Giannotta, G., Murrone, A., & Giannotta, N. (2023). COVID-19 mRNA vaccines: The molecular basis of some adverse events. Vaccines, 11(4), 747. DOI: https://doi.org/10.3390/vaccines11040747

Goel, R. R., Painter, M. M., Apostolidis, S. A., Mathew, D., Meng, W., Rosenfeld, A. M., Lundgreen, K. A., Reynaldi, A., Khoury, D. S., Pattekar, A., Gouma, S., Kuri-Cervantes, L., Hicks, P., Dysinger, S., Hicks, A., Sharma, H., Herring, S., Korte, S., Baxter, A. E., . . . Wherry, E. J. (2021). mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern. Science, 374(6572), abm0829. DOI: https://doi.org/10.1126/science.abm0829

Gote, V., Bolla, P. K., Kommineni, N., Butreddy, A., Nukala, P. K., Palakurthi, S. S., & Khan, W. (2023). A comprehensive review of mRNA vaccines. International Journal of Molecular Sciences, 24(3), 2700. DOI: https://doi.org/10.3390/ijms24032700

Grigoryan, L., & Pulendran, B. (2020). The immunology of SARS-CoV-2 infections and vaccines. Seminars in Immunology, 50, 101422. DOI: https://doi.org/10.1016/j.smim.2020.101422

Guo, M., Liu, X., Chen, X., & Li, Q. (2023). Insights into new-onset autoimmune diseases after COVID-19 vaccination. Autoimmunity Reviews, 22(7), 103340. DOI: https://doi.org/10.1016/j.autrev.2023.103340

Haimei, M. (2021). Concern about the adverse effects of thrombocytopenia and thrombosis after adenovirus-vectored COVID-19 vaccination. Clinical and Applied Thrombosis/Hemostasis, 27, 107602962110401. DOI: https://doi.org/10.1177/10760296211040110

Hilts, A., Schreiber, A., & Singh, A. (2022). A clinical case of COVID-19 vaccine-associated Guillain-Barré syndrome. American Journal of Case Reports, 23, e936896. DOI: https://doi.org/10.12659/ajcr.936896

Ilyas, U., Umar, Z., Bhangal, R., Shah, D., & Fayman, B. (2022). Guillain-Barré syndrome: A sequela of the original COVID-19 infection or vaccination. Cureus, 14(8), e28044. DOI: https://doi.org/10.7759/cureus.28044

Jara, L. J., Vera-Lastra, O., Mahroum, N., Pineda, C., & Shoenfeld, Y. (2022). Autoimmune post-COVID vaccine syndromes: Does the spectrum of autoimmune/inflammatory syndrome expand? Clinical Rheumatology, 41(5), 1603-1609. DOI: https://doi.org/10.1007/s10067-022-06149-4

Jaycox, J. R., Lucas, C., Yildirim, I., Dai, Y., Wang, E. Y., Monteiro, V., Lord, S., Carlin, J., Kita, M., Buckner, J. H., Ma, S., Campbell, M., Ko, A., Omer, S., Lucas, C. L., Speake, C., Iwasaki, A., & Ring, A. M. (2023). SARS-CoV-2 mRNA vaccines decouple anti-viral immunity from humoral autoimmunity. Nature Communications, 14(1), 1299. DOI: https://doi.org/10.1038/s41467-023-36686-8

Kamoi, K., & Ohno-Matsui, K. (2024). Long vax in the eye: Long post-COVID vaccination syndrome presenting with frosted branch angiitis. Diseases, 12(2), 36. DOI: https://doi.org/10.3390/diseases12020036

Karpiński, T. M., Ożarowski, M., Seremak-Mrozikiewicz, A., Wolski, H., & Wlodkowic, D. (2020). The 2020 race towards SARS-CoV-2 specific vaccines. Theranostics, 11(4), 1690-1702. DOI: https://doi.org/10.7150/thno.53691

Kashte, S., Gulbake, A., El-Amin, S. F., III, & Gupta, A. (2021). COVID-19 vaccines: Rapid development, implications, challenges and future prospects. Human Cell, 34(3), 711-733. DOI: https://doi.org/10.1007/s13577-021-00512-4

Kim, M. S., Lee, H., Lee, S. W., Kwon, R., Rhee, S. Y., Lee, J. A., Koyanagi, A., Smith, L., Fond, G., Boyer, L., Lee, J., Rahmati, M., Shin, J., Min, C., Shin, J. I., & Yon, D. K. (2024). Long-term autoimmune inflammatory rheumatic outcomes of COVID-19. Annals of Internal Medicine, 177(3), 291-302. DOI: https://doi.org/10.7326/m23-1831

Knezevic, I., Liu, M. A., Peden, K., Zhou, T., & Kang, H. (2021). Development of mRNA vaccines: Scientific and regulatory issues. Vaccines, 9(2), 81. DOI: https://doi.org/10.3390/vaccines9020081

Knight, R., Walker, V., Ip, S., Cooper, J. A., Bolton, T., Keene, S., Denholm, R., Akbari, A., Abbasizanjani, H., Torabi, F., Omigie, E., Hollings, S., North, T., Toms, R., Jiang, X., Di Angelantonio, E., Denaxas, S., Thygesen, J. H., Tomlinson, C., . . . Sterne, J. A. (2022).
Association of COVID-19 with major arterial and venous thrombotic diseases: A population-wide cohort study of 48 million adults in England and Wales. Circulation, 146(12), 892-906. DOI: https://doi.org/10.1161/circulationaha.122.060785

Korem, S., Gandhi, H., & Dayag, D. B. (2020). Guillain-Barré syndrome associated with COVID-19 disease. BMJ Case Reports, 13(9), e237215. DOI: https://doi.org/10.1136/bcr-2020-237215

Kouhpayeh, H., & Ansari, H. (2022). Adverse events following COVID-19 vaccination: A systematic review and meta-analysis. International Immunopharmacology, 109, 108906. DOI: https://doi.org/10.1016/j.intimp.2022.108906

Lam, I. C. H., Zhang, R., Man, K. K. C., Wong, C. K. H., Chui, C. S. L., Lai, F. T. T., Li, X., Chan, E. W. Y., Lau, C. S., Wong, I. C. K., & Wan, E. Y. F. (2024). Persistence in risk and effect of COVID-19 vaccination on long-term health consequences after SARS-CoV-2 infection. Nature Communications, 15(1), 1716. DOI: https://doi.org/10.1038/s41467-024-45953-1

Mahdiabadi, S., & Rezaei, N. (2022). Anaphylaxis and allergic reactions to COVID-19 vaccines: A narrative review of characteristics and potential obstacles on achieving herd immunity. Health Science Reports, 5(5), e787. DOI: https://doi.org/10.1002/hsr2.787

Mercadé-Besora, N., Li, X., Kolde, R., Trinh, N. T., Sanchez-Santos, M. T., Man, W. Y., Roel, E., Reyes, C., Delmestri, A., Nordeng, H. M. E., Uusküla, A., Duarte-Salles, T., Prats, C., Prieto-Alhambra, D., Jödicke, A. M., & Català, M. (2024). The role of COVID-19 vaccines in preventing post-COVID-19 thromboembolic and cardiovascular complications. Heart, 110(9), 635-643. DOI: https://doi.org/10.1136/heartjnl-2023-323483

Mushtaq, H. A., Khedr, A., Koritala, T., Bartlett, B. N., Jain, N. K., & Khan, S. A. (2022). A review of adverse effects of COVID-19 vaccines. Infezioni in Medicina, 30(1), 1-10. DOI: https://doi.org/10.53854/liim-3001-1

Nasergivehchi, S., Togha, M., Jafari, E., Sheikhvatan, M., & Shahamati, D. (2023). Headache following vaccination against COVID-19 among healthcare workers with a history of COVID-19 infection: A cross-sectional study in Iran with a meta-analytic review of the literature. Head & Face Medicine, 19(1), 19. DOI: https://doi.org/10.1186/s13005-023-00363-4

Oliver, S. E., Gargano, J. W., Marin, M., Wallace, M., Curran, K. G., Chamberland, M., McClung, N., Campos-Outcalt, D., Morgan, R. L., Mbaeyi, S., Romero, J. R., Talbot, H. K., Lee, G. M., Bell, B. P., & Dooling, K. (2020). The Advisory Committee on Immunization Practices’ interim recommendation for use of Pfizer-BioNTech COVID-19 vaccine — United States, December 2020. MMWR Morbidity and Mortality Weekly Report, 69(50), 1922-1924. DOI: https://doi.org/10.15585/mmwr.mm6950e2

Park, H. J., Gonsalves, G. S., Tan, S. T., Kelly, J. D., Rutherford, G. W., Wachter, R. M., Schechter, R., Paltiel, A. D., & Lo, N. C. (2024). Comparing frequency of booster vaccination to prevent severe COVID-19 by risk group in the United States. Nature Communications, 15(1), 1883. DOI: https://doi.org/10.1038/s41467-024-45549-9

Pereira, B., Xu, X., & Akbar, A. N. (2020). Targeting inflammation and immunosenescence to improve vaccine responses in the elderly. Frontiers in Immunology, 11, 583019. DOI: https://doi.org/10.3389/fimmu.2020.583019

Randolph, H. E., & Barreiro, L. B. (2020). Herd immunity: Understanding COVID-19. Immunity, 52(5), 737-741. DOI: https://doi.org/10.1016/j.immuni.2020.04.012

Rocco, J. M., Mallarino-Haeger, C., Randolph, A. H., Ray, S. M., Schechter, M. C., Zerbe, C. S., Holland, S. M., & Sereti, I. (2021). Hyperinflammatory syndromes after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) messenger RNA vaccination in individuals with underlying immune dysregulation. Clinical Infectious Diseases, 75(1), e912-e915. DOI: https://doi.org/10.1093/cid/ciab1024

Rose, J., Hulscher, N., & McCullough, P. A. (2024). Determinants of COVID-19 vaccine-induced myocarditis. Therapeutic Advances in Drug Safety, 15, 20420986241226566. DOI: https://doi.org/10.1177/20420986241226566

Sachdeva, A., & Saha, A. (2021). COVID-19 vaccine: A way out of crisis. In IntechOpen eBooks. DOI: https://doi.org/10.5772/intechopen.98736

Safety of COVID-19 Vaccines. (2020, February 10). CDC. Last access: August 10, 2024, Available at: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/safety-of-vaccines.html?s_cid=10508:covid%20vaccine%20long%20term%20side%20effects:sem.ga:p:RG:GM:gen:PTN:FY21

Saposnik, G., Bushnell, C., Coutinho, J. M., Field, T. S., Furie, K. L., Galadanci, N., Kam, W., Kirkham, F. C., McNair, N. D., Singhal, A. B., Thijs, V., & Yang, V. X. (2024). Diagnosis and management of cerebral venous thrombosis: A scientific statement from the american heart association. Stroke, 55(3), e77-e90. DOI: https://doi.org/10.1161/str.0000000000000456

Saputra, P. B. T., Kurniawan, R. B., Trilistyoati, D., Farabi, M. J. A., Susilo, H., Alsagaff, M. Y., Oktaviono, Y. H., Sutanto, H., Gusnanto, A., & Wungu, C. D. K. (2023). Myocarditis and coronavirus disease 2019 vaccination: A systematic review and meta-summary of cases. Biomolecules and Biomedicine, 23(4), 546-567. DOI: https://doi.org/10.17305/bb.2022.8779

Shan, J., Hu, X., Chen, T., Wang, Y., Huang, B., Xin, Y., & Xu, H. (2024). COVID-19 vaccination and the risk of autoimmune diseases: A Mendelian randomization study. Frontiers in Public Health, 12, 1322140. DOI: https://doi.org/10.3389/fpubh.2024.1322140

Srivastava, A., Sundararaj, S. N., Bhatia, J., & Arya, D. S. (2024). Understanding long COVID myocarditis: A comprehensive review. Cytokine, 178, 156584. DOI: https://doi.org/10.1016/j.cyto.2024.156584

Stati, G., Amerio, P., Nubile, M., Sancilio, S., Rossi, F., & Di Pietro, R. (2023). Concern about the effectiveness of mRNA vaccination technology and its long-term safety: Potential interference on miRNA machinery. International Journal of Molecular Sciences, 24(2), 1404. DOI: https://doi.org/10.3390/ijms24021404

Sumirtanurdin, R., & Barliana, M. I. (2021). Coronavirus disease 2019 vaccine development: An overview. Viral Immunology, 34(3), 134-144. DOI: https://doi.org/10.1089/vim.2020.0119

Taylor, S., & Asmundson, G. J. (2021). Immunization stress-related responses: Implications for vaccination hesitancy and vaccination processes during the COVID-19 pandemic. Journal of Anxiety Disorders, 84, 102489. DOI: https://doi.org/10.1016/j.janxdis.2021.102489

Tschöpe, C., Ammirati, E., Bozkurt, B., Caforio, A. L. P., Cooper, L. T., Felix, S. B., Hare, J. M., Heidecker, B., Heymans, S., Hübner, N., Kelle, S., Klingel, K., Maatz, H., Parwani, A. S., Spillmann, F., Starling, R. C., Tsutsui, H., Seferovic, P., & Van Linthout, S. (2020). Myocarditis and inflammatory cardiomyopathy: Current evidence and future directions. Nature Reviews Cardiology, 18(3), 169-193. DOI: https://doi.org/10.1038/s41569-020-00435-x

Wollina, U., Chiriac, A., Kocic, H., Koch, A., & Brzezinski, P. (2021). Cutaneous and hypersensitivity reactions associated with COVID-19 vaccination—A narrative review. Wiener Medizinische Wochenschrift, 172(3-4), 63-69. DOI: https://doi.org/10.1007/s10354-021-00876-0

Woo, W., Kim, A., Yon, D. K., Lee, S. W., Hwang, J., Jacob, L., Koyanagi, A., Kim, M., Moon, D. H., Jung, J., Choi, J., Jung, S. Y., Eun, L., Lee, S., Shin, J., & Smith, L. (2021). Clinical characteristics and prognostic factors of myocarditis associated with the mRNA COVID-19 vaccine. Journal of Medical Virology, 94(4), 1566-1580. DOI: https://doi.org/10.1002/jmv.27501

Xu, K., Wang, Z., Qin, M., Gao, Y., Luo, N., Xie, W., Zou, Y., Wang, J., & Ma, X. (2023). A systematic review and meta-analysis of the effectiveness and safety of COVID-19 vaccination in older adults. Frontiers in Immunology, 14, 1113156. DOI: https://doi.org/10.3389/fimmu.2023.1113156

Yan, Z., Yang, M., & Lai, C. (2021). COVID-19 Vaccinations: A comprehensive review of their safety and efficacy in special populations. Vaccines, 9(10), 1097. DOI: https://doi.org/10.3390/vaccines9101097

Yoshida, M., Kobashi, Y., Kawamura, T., Shimazu, Y., Nishikawa, Y., Omata, F., Saito, H., Yamamoto, C., Zhao, T., Takita, M., Ito, N., Tatsuno, K., Kaneko, Y., Nakayama, A., Kodama, T., Wakui, M., Takahashi, K., & Tsubokura, M. (2023). Association of systemic adverse reaction patterns with long-term dynamics of humoral and cellular immunity after coronavirus disease 2019 third vaccination. Scientific Reports, 13(1), 9264. DOI: https://doi.org/10.1038/s41598-023-36429-1
How to Cite
Yan, M., & Schmidt, S. (2024). Long Complications of COVID Vaccination. Science Insights, 45(3), 1515–1522. https://doi.org/10.15354/si.24.re1055
Section
Review